A nanoparticle depot formulation of 4-(N)-stearoyl gemcitabine shows a strong anti-tumour activity

OBJECTIVES: Depot formulation as a carrier for cytotoxic chemotherapeutic drugs is not well studied. The objective of this study is to test the feasibility of using a subcutaneous depot formulation to administer a cytotoxic anti-cancer drug for systemic therapy. METHODS: A fatty-acid amide prodrug o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhu, Saijie, Li, Xinran, Lansakara-P, Dharmika S P, Kumar, Amit, Cui, Zhengrong
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2012
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3539214/
https://ncbi.nlm.nih.gov/pubmed/23278691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.2042-7158.2012.01599.x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares